Example: Heart Attack

Clinical Trials on Papillomavirus Infections

Total 125 results

NCT02858310

Recruiting

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Conditions: Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ, Vulvar Neoplasms, Vulvar Diseases
NCT04772534

Recruiting

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

Conditions: Papillomavirus Infections
NCT04910438

Not yet recruiting

Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.

Conditions: Papillomavirus Infections, HIV Infections
NCT04708041

Recruiting

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Conditions: Papillomavirus Infections
NCT04724980

Recruiting

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Conditions: Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae
NCT04015336

Suspended

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Conditions: Papillomavirus Infections, Oropharyngeal Neoplasms
NCT04199689

Active, not recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Conditions: Papillomavirus Infections
NCT02897232

Completed

Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Conditions: Papillomavirus Infections, Health Behavior, Attitude of Health Personnel, Human Papilloma Virus, Male
NCT00973856

Completed

Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands

Conditions: Papillomavirus Infections, Warts, Condylomata Acuminata, Epidermodysplasia Verruciformis
NCT03903562

Active, not recruiting

Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)

Conditions: Papillomavirus Infections
NCT04694495

Recruiting

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Conditions: Papillomavirus Infections, Uterine Cervical Neoplasms, Sexual Transmitted Disease
NCT04671823

Not yet recruiting

Changes in the Prevalence of Oncogenic HPV Types

Conditions: Papillomavirus Vaccines, Papillomavirus Infections
NCT03610581

Terminated

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Conditions: Human Papillomavirus Infections
NCT03998254

Active, not recruiting

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

Conditions: Papillomavirus Infections
NCT03981822

Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Conditions: Condylomata Acuminata, Papillomavirus Infections, Skin Diseases, Viral, Skin Diseases, Infectious, Skin Diseases, Sexually Transmitted Diseases, Viral, Sexually Transmitted Diseases, Warts
NCT00947115

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Conditions: Infections, Papillomavirus
NCT04587050

Not yet recruiting

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV

Conditions: HIV Infections, Human Papillomavirus Infection, Cervical Cancer
NCT04044950

Withdrawn

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Conditions: Papillomavirus Infections, Oropharyngeal Neoplasms
NCT01031069

Completed

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Conditions: Infections, Papillomavirus, Papillomavirus Vaccines
NCT03929172

Completed

A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Conditions: Papillomavirus Infections
NCT01381575

Completed

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Conditions: Infections, Papillomavirus
NCT04124198

Recruiting

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

Conditions: Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Oropharyngeal Neoplasms, Neoplasms, Squamous Cell, Neoplasms, Glandular and Epithelial, Neoplasms by Histologic Type, Pharyngeal Neoplasms Malignant and Unspecified, Otorhinolaryngologic Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Diseases, Pharyngeal Diseases, Papillomavirus Infections, Virus Diseases, DNA Virus Infections, Tumor Virus Infections, Quality of Life
NCT04000503

Recruiting

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

Conditions: Human Papillomavirus 16, Human Papillomavirus 18, Papillomavirus Infections, Cervical Cancer, Pre-Cancerous Dysplasia
NCT01627561

Completed

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Conditions: Infections, Papillomavirus
NCT03546842

Completed

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Conditions: Papillomavirus Infections, Uterine Cervical Neoplasms, Vulvar Neoplasms, Vaginal Neoplasms, Adenocarcinoma in Situ, Condylomata Acuminata